Health Resources Of Arkansas Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 623 N 9th St, Augusta, AR 72006 Phone: 870-793-8900 Fax: 870-793-8959 |
Midsouth Health Systems Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 623 N 9th St Ste 200, Augusta, AR 72006 Phone: 870-972-4939 Fax: 870-972-4911 |
Pine Valley Day Treatment Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 893 Highway 64, Augusta, AR 72006 Phone: 870-347-5908 Fax: 870-347-1457 |
Health Resources Of Arkansas, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 623 N 9th St, Augusta, AR 72006 Phone: 870-347-3254 Fax: 870-347-5556 |
News Archive
CorMatrix Cardiovascular, Inc., a medical device company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, announced today that a retrospective study demonstrated that reconstructing the pericardium using ECM Technology in patients undergoing primary isolated coronary artery bypass grafting (CABG) contributed to a statistically significant and clinically meaningful reduction in the rate of new onset postoperative atrial fibrillation.
When a muscle is damaged, dormant adult stem cells called satellite cells are signaled to "wake up" and contribute to repairing the muscle. University of Missouri researchers recently found how even distant satellite cells could help with the repair, and are now learning how the stem cells travel within the tissue.
There is a growing need for Cognitive Rehabilitation Therapy (CRT) due to the huge influx of soldiers returning from war zones with brain injuries, athletes with sports-related head injuries, and the growing population with age-related cognitive decline.
Hand-washing, a clean environment, appropriate infection barriers and early identification of patients at high risk of colonization with a transmissible microorganism remain the essential measures to prevent and control infection.
In this post in the Guardian's "The Observer," Mark Honigsbaum, a research associate at the University of Zurich's Institute for Medical History, interviews Peter Seeberger, the director of the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, about a recent announcement that Seeberger and colleague François Lévesque "have discovered a simple and cost-effective way of synthesizing artemisinin from the waste products of the" sweet wormwood plant from which it is extracted.
› Verified 3 days ago